Get started
Harrow, Inc. - 11.875% Senior Notes due 2027Harrow, Inc. - 11.875% Senior Notes due 2027Harrow, Inc. - 11.875% Senior Notes due 2027

Harrow, Inc. - 11.875% Senior Notes due 2027

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

HROWM chart


Full chart

HROWM upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪1.40 B‬ USD
Dividend yield (indicated)
8.56%
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.29 USD
Net income (FY)
‪−17.48 M‬ USD
Revenue (FY)
‪199.61 M‬ USD
Shares float
‪30.86 M‬
Beta (1Y)
0.05

Employees


Employees (FY)
382
Change (1Y)
+67 +21.27%
Revenue / Employee (1Y)
‪522.55 K‬ USD
Net income / Employee (1Y)
‪−45.76 K‬ USD

About Harrow, Inc.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Mark L. Baum
Website
harrow.com
Headquarters
Nashville
Founded
2006
ISIN
US4158583074
FIGI
BBG01BZ7DBV7
Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer on January 11, 2006 and is headquartered in Nashville, TN.

Check out other big names from the same industry as HROWM.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

HROWM news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of HROWM is 26.18 USD — it has decreased by −0.28% in the past 24 hours. Watch Harrow, Inc. - 11.875% Senior Notes due 2027 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Harrow, Inc. - 11.875% Senior Notes due 2027 stocks are traded under the ticker HROWM.
HROWM stock has risen by 0.64% compared to the previous week, the month change is a −1.48% fall, over the last year Harrow, Inc. - 11.875% Senior Notes due 2027 has showed a 0.46% increase.
HROWM reached its all-time high on Mar 1, 2024 with the price of 27.72 USD, and its all-time low was 22.71 USD and was reached on Nov 14, 2023. View more price dynamics on HROWM chart.
See other stocks reaching their highest and lowest prices.
HROWM stock is 0.58% volatile and has beta coefficient of 0.05. Track Harrow, Inc. - 11.875% Senior Notes due 2027 stock price on the chart and check out the list of the most volatile stocks — is Harrow, Inc. - 11.875% Senior Notes due 2027 there?
Today Harrow, Inc. - 11.875% Senior Notes due 2027 has the market capitalization of ‪1.40 B‬, it has increased by 4.39% over the last week.
Yes, you can track Harrow, Inc. - 11.875% Senior Notes due 2027 financials in yearly and quarterly reports right on TradingView.
Harrow, Inc. - 11.875% Senior Notes due 2027 is going to release the next earnings report on Nov 17, 2025. Keep track of upcoming events with our Earnings Calendar.
HROWM earnings for the last quarter are 0.13 USD per share, whereas the estimation was 0.01 USD resulting in a ‪1.62 K‬% surprise. The estimated earnings for the next quarter are 0.23 USD per share. See more details about Harrow, Inc. - 11.875% Senior Notes due 2027 earnings.
Harrow, Inc. - 11.875% Senior Notes due 2027 revenue for the last quarter amounts to ‪63.74 M‬ USD, despite the estimated figure of ‪66.00 M‬ USD. In the next quarter, revenue is expected to reach ‪73.95 M‬ USD.
HROWM net income for the last quarter is ‪5.00 M‬ USD, while the quarter before that showed ‪−17.78 M‬ USD of net income which accounts for 128.09% change. Track more Harrow, Inc. - 11.875% Senior Notes due 2027 financial stats to get the full picture.
Yes, HROWM dividends are paid quarterly. The last dividend per share was 0.74 USD. As of today, Dividend Yield (TTM)% is 0.00%. Tracking Harrow, Inc. - 11.875% Senior Notes due 2027 dividends might help you take more informed decisions.
As of Sep 4, 2025, the company has 382 employees. See our rating of the largest employees — is Harrow, Inc. - 11.875% Senior Notes due 2027 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Harrow, Inc. - 11.875% Senior Notes due 2027 EBITDA is ‪32.62 M‬ USD, and current EBITDA margin is 11.47%. See more stats in Harrow, Inc. - 11.875% Senior Notes due 2027 financial statements.
Like other stocks, HROWM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Harrow, Inc. - 11.875% Senior Notes due 2027 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Harrow, Inc. - 11.875% Senior Notes due 2027 technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Harrow, Inc. - 11.875% Senior Notes due 2027 stock shows the sell signal. See more of Harrow, Inc. - 11.875% Senior Notes due 2027 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.